Accelerating Australia - Stage 2
Accelerating Australia is a national consortium of biomedical research institutions, universities, healthcare providers and companies.
The project facilitates the translation of biomedical research through entrepreneurial experience courses, brokerage and early stage commercialisation support services, collaborating across sectors, organisations, disciplines and support services. The project also aims to identify promising biomedical products and assist in bringing them to production.
Outcomes: Accelerating Australia continues to run programs in Western Australia, South Australia, New South Wales and Victoria, with affiliates in Queensland and Tasmania. Almost 1400 individuals have received commercialisation training resulting in over 160 medical products being developed. There is improved collaboration between universities and companies within each state node.
| State | Western Australia |
| Consortium lead | Centre for Entrepreneurial Research and Innovation (CERI) |
| Consortium members | The University of Western Australia, Monash University, The University of Adelaide, The University of Melbourne, University of Technology Sydney, The University of Sydney, Orthocell, Avita Medical Ltd, Proteomics International, Murdoch University, Curtin University of Technology, Edith Cowan University, Macquarie University, Harry Perkins Institute of Medical Research, Telethon Kids Institute, Lions Eye Institute, Ear Science Institute Australia, Perron Institute for Neurological and Translational Science Australia, St John of God Healthcare |
| MTPConnect grant | $1,000,000 |
| Industry contribution | $2,870,135 |
| Other Government Contribution | $5,000 |
| Project duration | May 2018 - March 2020 (Finished) |
| Contact | Kevin Pfleger, Harry Perkins Institute of Medical Research |
Visit Accelerating Australia for more details | Twitter: acceleratingaus | LinkedIn: Accelerating Australia